Keywords: USA, Obama budget, Generic settlements, Pay-for-delay, Biosimilars, Biologics, FTC, FDA, PhRMA, GPhA, User fees

US R&D and copy drugmaker slam Obama budget plans to back generics

Article | 15 February 2011

US President Barack Obama yesterday unveiled a $3.73 budget request which contains several provisions that affect the pharmaceutical industry with regard ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in